Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

It is clear that CD4(+)  CD25(+)  Foxp3(+) regulatory T (Treg) cells inhibit chronic inflammatory responses as well as adaptive immune responses. Among the CD4(+) T-cell population in the skin, at least one-fifth express Foxp3. As the skin is constantly exposed to antigenic challenge and is a common site of vaccination, understanding the role of these skin-resident Treg cells is important. Although the suppressive effect of Treg cells on T cells is well documented, less is known about the types of innate immune cells influenced by Treg cells and whether the Treg cells suppress acute innate immune responses in vivo. To address this we used a mouse melanoma cell line expressing Fas ligand (B16FasL), which induces an inflammatory response following subcutaneous injection of mice. We demonstrate that Treg cells limit this response by inhibiting neutrophil accumulation and survival within hours of tumour cell inoculation. This effect, which was associated with decreased expression of the neutrophil chemoattractants CXCL1 and CXCL2, promoted survival of the inoculated tumour cells. Overall, these data imply that Treg cells in the skin are rapidly mobilized and that this activity serves to limit the amplification of inflammatory responses at this site.

Original publication

DOI

10.1111/j.1365-2567.2010.03333.x

Type

Journal article

Journal

Immunology

Publication Date

12/2010

Volume

131

Pages

583 - 592

Addresses

Infection, Immunity and Biochemistry, School of Medicine, Heath Park, Cardiff , UK.

Keywords

Neutrophils, Cell Line, Tumor, Skin, Animals, Mice, Melanoma, Skin Neoplasms, Neutrophil Infiltration, Time Factors, T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Fas Ligand Protein, Chemokine CXCL1, Chemokine CXCL2, Immunity, Innate